Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

AMEDISYS INC

CIK: 8962622 Annual ReportsLatest: 2025-04-29

10-K / April 29, 2025

Revenue:$2,348,000,000
Income:$38,162,000

10-K / April 26, 2024

Revenue:$2,236,400,000
Income:-$9,747,000

10-K / April 29, 2025

Company Summary: Amedisys, Inc.

Overview: Amedisys, Inc. is a healthcare services provider primarily focused on home health care, hospice, and personal care services. The company operates in the United States and serves a substantial patient base, with a focus on high-quality patient care and operational growth.

Business Operations in 2024:

  • Patients Cared For: Over 499,000
  • Patient Visits: More than 10.7 million visits
  • Care Specialties: Home health care, hospice care, high acuity care, and personal care services
  • Admissions Growth in 2024:
    • Home health same-store total admissions grew by 11%
    • High-acuity care total admissions increased by 38%, reaching its highest volume since inception
    • Hospice daily census increased for the first time since 2020

Financial Highlights for 2024:

  • Revenue: $2.348 billion (compared to $2.236 billion in 2023)
  • Cash Flow from Operations: $222 million
  • Quality Scores:
    • Home Health Compare star rating: 4.18 stars (industry best)
    • 88% of care centers rated at 4+ stars
    • Patient Satisfaction Star Score: 4.02 (outperforming industry average)
    • Outperformed industry on Hospice Item Set (HIS) measures

Employees: While exact employee count isn’t provided in the excerpt, the company emphasizes its operational scale and focused on managing a significant healthcare workforce to deliver services efficiently.

Stock Information:

  • Stock Ticker: AMED (traded on NASDAQ)
  • Outstanding Shares: 32,819,638 as of April 25, 2025
  • Market Capitalization (as of June 28, 2024): $3.0 billion

Overall: Amedisys, Inc. provides extensive home-based healthcare and hospice services across the U.S., with a focus on high-quality patient outcomes, operational growth, and a significant patient volume, supporting its position as a leading provider in its industry.